The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial

Pernille Lassen, Jesper G Eriksen, Annelise Krogdahl, Marianne Hamilton Therkildsen, Benedicte P Ulhøi, Marie Overgaard, Lena Specht, Elo Verner Andersen, Jørgen Johansen, Lisbeth Juhler Andersen, Cai Grau, Jens Overgaard, Danish Head and Neck Cancer Group (DAHANCA)

Research output: Contribution to journalJournal articleResearchpeer-review

135 Citations (Scopus)
Original languageEnglish
JournalRadiotherapy & Oncology
Volume100
Pages (from-to)49-55
Number of pages7
ISSN0167-8140
DOIs
Publication statusPublished - 2011
Externally publishedYes

Bibliographical note

Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Carcinoma, Squamous Cell
  • Dose Fractionation
  • Female
  • Head and Neck Neoplasms
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Proteins
  • Papillomaviridae
  • Proportional Hazards Models

Fingerprint

Dive into the research topics of 'The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial'. Together they form a unique fingerprint.

Cite this